50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Our mission is to transform cancer care.”In use 2018 – now·1 sighting·SEC Form 10-K, filed 2018-03-0788% match
“Our mission is to heal and empower cancer patients through compassion, innovation, and state-of-the-art medical care.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-2879% match
“Our mission is to target cancer and transform lives through the development of innovative cancer treatments.”In use 2005 – now·1 sighting·SEC Form 10-K, filed 2005-03-1678% match
“Our mission is to transform cancer treatment and prevention globally by driving technological innovation and accelerating the adoption of precision oncology medicine.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-06-2278% match
“Our mission is to transform the active management of cancer through personalized testing.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-02-2377% match
“Our mission is to create new standards of care for patients with cancer.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-0976% match
“Our mission is to accelerate transformative therapies to improve the lives of people living with cancer and other serious diseases.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-02-2376% match
“Our mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-03-0676% match
“Our mission is to transform the lives of cancer patients by providing innovative solutions to enable targeted delivery of therapeutic agents.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3075% match
“Our mission is to transform deadly cancer into a chronic and eventually curable disease.”In use 2025 – now·1 sighting·SEC Form 20-F/A, filed 2025-05-1275% match
“Our mission is to eliminate cancer and improve life.”In use 2021 – now·1 sighting·SEC Form 20-F, filed 2021-03-2475% match
“Our mission is to help improve the lives of those affected by cancer through translating cancer discoveries into better patient care.”In use 2010 – now·1 sighting·SEC Form 10-K, filed 2010-03-1674% match
“Our mission is to discover, develop and ultimately deliver medicines that are transformational for patients.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-2874% match
“Our mission is to transform care delivery and support healthier individuals and communities.”In use 2023 – now·1 sighting·SEC Form S-1, filed 2023-04-0774% match
“Our mission is to become a leader in bringing innovative cancer treatments to the market and to improve patient health outcomes.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2073% match
“Our mission is to increase access to and advance the delivery of high-quality cancer care in America.”In use 2008 – now·1 sighting·SEC Form 10-K, filed 2008-02-2973% match
“Our mission is to change the landscape of oncology drug discovery and enable the development of more effective therapies for the treatment of cancer.”In use 2025 – now·1 sighting·SEC Form S-1, filed 2025-07-1873% match
“Our mission is to help accelerate its transformation to a value-based care system from which everyone benefits.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-05-2673% match
“Our mission is to build a leading oncology company that creates novel and transformative treatments for a wide range of oncology indications for which there are significant unmet medical needs.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-0772% match
“Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1772% match
“Our mission is to bring forth the next wave of precision oncology therapies that are more selective, more effective and deeply personalized with the goal of altering the course of disease and improving clinical outcomes for patients with cancer.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1772% match
“Our mission is to improve the lives of patients by developing novel therapeutics to treat some of the most devastating types of cancer.”In use 2026 – now·1 sighting·SEC Form 10-K/A, filed 2026-06-0272% match
“Our mission is to improve outcomes for patients living with cancer and genetically defined conditions.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0272% match
“Our mission is to save lives by improving patient care.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1772% match
“Our mission is to serve patients.”In use 2012 – now·1 sighting·SEC Form 10-K, filed 2012-02-2972% match
“Our mission is to become a global leader in developing better and safer radioimmunotherapy and antibody-based oncology therapies addressing clear unmet medical needs and, as such, have a transformational impact on the lives of patients.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-0471% match
“Our mission is to combine the ingenuity of people with the power of data and technology to achieve new victories against cancer.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-11-2571% match
“Our mission is to transform health care for all through our human-centered, technology-powered model.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-02-2271% match
“The Company’s mission is to transform healthcare by providing innovative services that improve outcomes, reduce costs and deliver hope for patients and their families.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2471% match
“Our mission is to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte, or TIL, cell therapies for patients with solid tumor cancers.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2471% match
“Our mission is to create, develop, manufacture, and deliver cell and gene therapies to transform the lives of people impacted by life-threatening diseases.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1871% match
“Our mission is to provide a comprehensive and personalized approach to the clinical management of cancer through improved diagnostic, prognostic and therapeutic interventions.”In use 2010 – now·1 sighting·SEC Form 10-K, filed 2010-05-1771% match
“Our mission is to deliver transformative therapeutics to those in need, and we believe our innovative EDO technology is well-positioned to effect this change for patients, families and the broader healthcare community.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0471% match
“Our mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2671% match
“Our mission is to improve the quality of life of people suffering from cancer and to increase shareholder value by commercializing our platform technologies through in-house development, joint ventures, strategic alliances and licensing arrangements.”In use 2003 – now·1 sighting·SEC Form 10-K, filed 2003-07-2971% match
“Our mission is to inspire hope for those battling cancer by expanding on the promise of targeted therapies.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-1571% match
“Our mission is to unite biopharma, physicians, and patients to transform the standard of care and improve outcomes with personalized diagnostics.”In use 2024 – now·1 sighting·SEC Form S-1/A, filed 2024-05-2471% match
“Our mission is to transform the lives of patients by creating medicines with improved therapeutic profiles for areas of unmet need.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2371% match
“Our mission is to make a meaningful impact on the lives of patients with cancer and high unmet medical needs by delivering novel, PRAME-directed immunotherapies that provide tangible clinical benefits.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-03-0571% match
“Our mission is to deliver curative, one-time administered genomic medicines that transform the lives of patients.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0270% match
“Our mission is to accelerate scientific and medical breakthroughs and deliver well-tolerated medicines with greater efficacy and safety to people with the deadliest cancers.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0570% match
“Our mission is to provide the best cancer care that is affordable and close to where patients live and work.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-2770% match
“Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1970% match
“Our mission is to build an oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0370% match
“Our mission is to transform the delivery of healthcare services in the communities we serve by implementing innovative population health models and creating a patient-centered, physician-centric experience in a high performance environment of integrated care.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-06-2970% match
“Our mission is to develop next-generation, potentially curative cell therapies for people with cancer.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1270% match
“Our mission is to transform cancer therapy by reducing normal tissue toxicity induced by radiotherapy and increasing the anti-cancer efficacy of radiotherapy with the use of our dismutase mimetics.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-0870% match
“Our mission is to reimagine therapeutics and their delivery.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-04-0170% match
“Our mission is to re-humanize healthcare by enabling doctors to practice medicine that is centered on patients.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-3070% match
“Our mission is to change the standard of care for patients with blood cancer by engineering hematopoietic stem cells (“HSCs”) to enable the use of targeted therapies post-transplant.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2370% match
Showing 1–50 of 50